Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: HIGHMARK WHOLECARE (FORMERLY GATEWAY HEALTH PLAN, LP.) · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health care regulatory matters; Medicare & Medicaid advantage; general issues. * S. 2011, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014, 101, 103, 401; * HR 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014, 2, 4; * HR 4302, Protecting Access to Medicare Act of 2014, 101, 107; * Advance Notice of Methodological Changes for Calendar Year (C4) 2015 for Medicare Advantage (MA) Capitation Rates, Parts C & D Payment Policies & 2015 Call Letter
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: UNIVERSITY OF PITTSBURGH MEDICAL CENTER · Firm: BUCHANAN INGERSOLL & ROONEY PC
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
GENERIC ANIMAL DRUG ALLIANCE via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · 1A
Legislative issues relating to United States Food & Drug Administration
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO via BUCHANAN INGERSOLL & ROONEY PC
2014 · fourth_quarter · 4T
Source: Senate LDA
| STERLING LIFE INSURANCE COMPANY |
| 20 |
| 2008–2012 |
| UNIVERSITY OF PITTSBURGH MEDICAL CENTER | 19 | 2006–2014 |
| FERRING PHARMACEUTICALS - USA | 15 | 2006–2013 |
| MCDONALD'S CORPORATION | 13 | 2009–2012 |
| GRAS/E COALITION | 12 | 2007–2008 |
| SABER HEALTHCARE GROUP | 12 | 2012–2014 |
| EQT CORPORATION | 9 | 2013–2014 |
| HIGHMARK WHOLECARE (FORMERLY GATEWAY HEALTH PLAN, LP.) | 9 | 2012–2014 |
| SAINT JOSEPH'S UNIVERSITY | 9 | 2013–2014 |
| AVID IDENTIFICATION SYSTEMS, INC | 8 | 2005–2008 |
| STIEFEL LABORATORIES, INC. | 8 | 2008–2009 |
| A VOICE FOR ALL INC | 7 | 2005–2008 |
| BROWN'S COMPOUNDING | 7 | 2013–2014 |
| MUNICH RE AMERICA | 7 | 2013–2014 |
| TRAFIGURA AG | 7 | 2009–2011 |
| US ONCOLOGY | 7 | 2007–2008 |
| BAA USA INC | 6 | 2005–2008 |
| HERITAGE VALLEY HEALTH SYSTEMS | 6 | 2013–2014 |
| SHIRE PHARMACEUTICALS, INC | 6 | 2008–2009 |
| CERIDIAN BENEFITS SERVICES INC | 5 | 2007–2008 |
| DOLLAR BANK | 5 | 2009–2010 |
| EFA PROCESSING | 5 | 2010–2011 |
| IDM PHARMA INC. | 5 | 2007 |
| POSIT SCIENCE | 5 | 2008–2009 |
| PROFESSIONAL AND SCIENTIFIC ASSOCIATES | 5 | 2006–2008 |
| RADIATION THERAPY ALLIANCE | 5 | 2009–2010 |
| SPORTINGBET PLC | 5 | 2006–2008 |
| VANTAGE ONCOLOGY | 5 | 2008–2009 |
| CATHOLIC HEALTH EAST | 4 | 2008 |
| UNIVERSITY OF THE SCIENCES IN PHILADELPHIA | 4 | 2013–2014 |
| ANRESCO INC | 3 | 2008 |
| CARIBBEAN CABLE COMMUNICATIONS | 3 | 2011 |
| DOSAL TOBACCO CORP INC | 3 | 2005 |
| ELGE INC. | 3 | 2008 |
| MANUFACTURERS AND TRADERS TRUST CO (M&T BANK) | 3 | 2012 |
| TMO RENEWABLES LTD | 3 | 2007–2008 |
| WARNEX | 3 | 2006–2007 |
| CBS CORP | 2 | 2006 |
| COMCAST CORPORATION | 2 | 2005–2006 |
| DAIICHI SANKYO | 2 | 2007 |
| HYBRIVET SYSTEMS INC. | 2 | 2010 |
| SCHOOL DISTRICT OF PHILADELPHIA | 2 | 2005–2006 |
| SHEFFIELD PHARMACEUTICALS | 2 | 2008 |
| FOUNDATION FOR INDEPENDENT HIGHER EDUCATION (FIHE) | 1 | 2005 |
| POINCIANA PARTNERS LLC | 1 | 2006 |
| WOCKHARDT LTD | 1 | 2014 |
HR 4302, Protecting Access to Medicare Act of 2014, PL113-93, 101, 107, 109, 212, 218, 221; HR 4015, SGR Repeal & Medicare Provider Payment Modernization Act of 2014; 2 & 4; 2015 Medicare Advantage (MA) Capitation Rates, Parts C&D Payment Policies & 2015 Call Letter, (4.7.14); S 2110, Medicare SGR Repeal & Beneficiary Access Improvement Act of 2014; 101, 103, 206, 404; ICD-10 Implementation; Medicaid & CHIP Payment and Access Commission - call for nominations
SGR Repeal and Medicare Provider Payment Modernization Act of 2014
Client: UNIVERSITY OF PITTSBURGH MEDICAL CENTER · Firm: BUCHANAN INGERSOLL & ROONEY PC
HR 4302, Protecting Access to Medicare Act of 2014, PL113-93, 101, 107, 109, 212, 218, 221; HR 4015, SGR Repeal & Medicare Provider Payment Modernization Act of 2014; 2 & 4; S 2110, Medicare SGR Repeal & Beneficiary Access Improvement Act of 2014; 101, 103, 206, 404; ICD-10 Implementation; Medicaid & CHIP Payment and Access Commission - call for nominations; Liver Transplant Request and Medicare Administrative Contractor; Draft legislation by Ways and Means to Improve Hospital Issues; Quality Reporting Measures
Protecting Access to Medicare Act of 2014
Client: UNIVERSITY OF PITTSBURGH MEDICAL CENTER · Firm: BUCHANAN INGERSOLL & ROONEY PC
HR 4302, Protecting Access to Medicare Act of 2014, PL113-93, 101, 107, 109, 212, 218, 221; HR 4015, SGR Repeal & Medicare Provider Payment Modernization Act of 2014; 2 & 4; 2015 Medicare Advantage (MA) Capitation Rates, Parts C&D Payment Policies & 2015 Call Letter, (4.7.14); S 2110, Medicare SGR Repeal & Beneficiary Access Improvement Act of 2014; 101, 103, 206, 404; ICD-10 Implementation; Medicaid & CHIP Payment and Access Commission - call for nominations
Protecting Access to Medicare Act of 2014
Client: HIGHMARK WHOLECARE (FORMERLY GATEWAY HEALTH PLAN, LP.) · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health care regulatory matters; Medicare & Medicaid advantage; general issues. * S. 2011, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014, 101, 103, 401; * HR 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014, 2, 4; * HR 4302, Protecting Access to Medicare Act of 2014, 101, 107; * Advance Notice of Methodological Changes for Calendar Year (C4) 2015 for Medicare Advantage (MA) Capitation Rates, Parts C & D Payment Policies & 2015 Call Letter
Protecting Access to Medicare Act of 2014
Client: UNIVERSITY OF PITTSBURGH MEDICAL CENTER · Firm: BUCHANAN INGERSOLL & ROONEY PC
HR 4302, Protecting Access to Medicare Act of 2014, PL113-93, 101, 107, 109, 212, 218, 221; HR 4015, SGR Repeal & Medicare Provider Payment Modernization Act of 2014; 2 & 4; S 2110, Medicare SGR Repeal & Beneficiary Access Improvement Act of 2014; 101, 103, 206, 404; ICD-10 Implementation; Medicaid & CHIP Payment and Access Commission - call for nominations; Liver Transplant Request and Medicare Administrative Contractor; Draft legislation by Ways and Means to Improve Hospital Issues; Quality Reporting Measures
Veteran Access to Care Act of 2014
Client: UNIVERSITY OF PITTSBURGH MEDICAL CENTER · Firm: BUCHANAN INGERSOLL & ROONEY PC
Implementation of PL111-148; S. 2450, HR 4810, Veterans Affairs Policy for Organ Transplant; specialty drugs' effect on health care premiums; long-term care policies
Veteran Access to Care Act of 2014
Client: UNIVERSITY OF PITTSBURGH MEDICAL CENTER · Firm: BUCHANAN INGERSOLL & ROONEY PC
Implementation of PL111-148; S. 2450, HR 4810, Veterans Affairs Policy for Organ Transplant; specialty drugs' effect on health care premiums; long-term care policies.
Veteran Access to Care Act of 2014
Client: UNIVERSITY OF PITTSBURGH MEDICAL CENTER · Firm: BUCHANAN INGERSOLL & ROONEY PC
Implementation of PL111-148; S. 2450, HR 4810, Veterans Affairs Policy for Organ Transplant; specialty drugs' effect on health care premiums; long-term care policies.
Stop Targeting of Political Beliefs by the IRS Act of 2014
Client: HIGHMARK WHOLECARE (FORMERLY GATEWAY HEALTH PLAN, LP.) · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health care regulatory matters; Medicare & Medicaid advantage; general issues. * S. 2011, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014, 101, 103, 401; * HR 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014, 2, 4; * HR 4302, Protecting Access to Medicare Act of 2014, 101, 107; * Advance Notice of Methodological Changes for Calendar Year (C4) 2015 for Medicare Advantage (MA) Capitation Rates, Parts C & D Payment Policies & 2015 Call Letter
Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014
Client: UNIVERSITY OF PITTSBURGH MEDICAL CENTER · Firm: BUCHANAN INGERSOLL & ROONEY PC
HR 4302, Protecting Access to Medicare Act of 2014, PL113-93, 101, 107, 109, 212, 218, 221; HR 4015, SGR Repeal & Medicare Provider Payment Modernization Act of 2014; 2 & 4; 2015 Medicare Advantage (MA) Capitation Rates, Parts C&D Payment Policies & 2015 Call Letter, (4.7.14); S 2110, Medicare SGR Repeal & Beneficiary Access Improvement Act of 2014; 101, 103, 206, 404; ICD-10 Implementation; Medicaid & CHIP Payment and Access Commission - call for nominations
Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014
Client: UNIVERSITY OF PITTSBURGH MEDICAL CENTER · Firm: BUCHANAN INGERSOLL & ROONEY PC
HR 4302, Protecting Access to Medicare Act of 2014, PL113-93, 101, 107, 109, 212, 218, 221; HR 4015, SGR Repeal & Medicare Provider Payment Modernization Act of 2014; 2 & 4; S 2110, Medicare SGR Repeal & Beneficiary Access Improvement Act of 2014; 101, 103, 206, 404; ICD-10 Implementation; Medicaid & CHIP Payment and Access Commission - call for nominations; Liver Transplant Request and Medicare Administrative Contractor; Draft legislation by Ways and Means to Improve Hospital Issues; Quality Reporting Measures
Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014
Client: UNIVERSITY OF PITTSBURGH MEDICAL CENTER · Firm: BUCHANAN INGERSOLL & ROONEY PC
Implementation of PL111-148; S. 2450, HR 4810, Veterans Affairs Policy for Organ Transplant; specialty drugs' effect on health care premiums; long-term care policies
Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014
Client: UNIVERSITY OF PITTSBURGH MEDICAL CENTER · Firm: BUCHANAN INGERSOLL & ROONEY PC
Implementation of PL111-148; S. 2450, HR 4810, Veterans Affairs Policy for Organ Transplant; specialty drugs' effect on health care premiums; long-term care policies.
Veterans' Access to Care through Choice, Accountability, and Transparency Act of 2014
Client: UNIVERSITY OF PITTSBURGH MEDICAL CENTER · Firm: BUCHANAN INGERSOLL & ROONEY PC
Implementation of PL111-148; S. 2450, HR 4810, Veterans Affairs Policy for Organ Transplant; specialty drugs' effect on health care premiums; long-term care policies.
Quality Care for Moms and Babies Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology; organized retail crime bill; drug pedigree legislation; health care reform; S.425 implementation; TRICARE issues; MTM legislation
Quality Care for Moms and Babies Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology; organized retail crime bill; drug pedigree legislation; health care reform; S.425 implementation; TRICARE issues; MTM legislation
Quality Care for Moms and Babies Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation, TRICARE issues; MTM legislation
Quality Care for Moms and Babies Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology; organized retail crime bill; drug pedigree legislation; health care reform; S.425 implementation; TRICARE issues; MTM legislation
Quality Care for Moms and Babies Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation, TRICARE issues; MTM legislation
Quality Care for Moms and Babies Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology; organized retail crime bill; drug pedigree legislation; health care reform; S.425 implementation; TRICARE issues; MTM legislation
Quality Care for Moms and Babies Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation, TRICARE issues; MTM legislation
Quality Care for Moms and Babies Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation, TRICARE issues; MTM legislation
Quality Care for Moms and Babies Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation, TRICARE issues; MTM legislation
Quality Care for Moms and Babies Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation, TRICARE issues; MTM legislation
Indonesian Family Refugee Protection Act
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425. Debit interchange fees
To suspend temporarily the duty on Disperse Blue 56.
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425. Debit interchange fees
Debt Settlement Consumer Protection Act of 2010
Client: DOLLAR BANK · Firm: BUCHANAN INGERSOLL & ROONEY PC
Banking issues related to charter HR 5387 S 3264
Debt Settlement Consumer Protection Act of 2010
Client: DOLLAR BANK · Firm: BUCHANAN INGERSOLL & ROONEY PC
Banking issues related to charter HR 5387 S 3264
Debt Settlement Consumer Protection Act of 2010
Client: DOLLAR BANK · Firm: BUCHANAN INGERSOLL & ROONEY PC
Banking issues related to charter HR 5387 S 3264
Debt Settlement Consumer Protection Act of 2010
Client: DOLLAR BANK · Firm: BUCHANAN INGERSOLL & ROONEY PC
Banking issues related to charter HR 5387 S 3264
Debt Settlement Consumer Protection Act of 2010
Client: DOLLAR BANK · Firm: BUCHANAN INGERSOLL & ROONEY PC
Banking issues related to charter HR 5387 S 3264
Debt Settlement Consumer Protection Act of 2010
Client: DOLLAR BANK · Firm: BUCHANAN INGERSOLL & ROONEY PC
Banking issues related to charter HR 5387 S 3264
Debt Settlement Consumer Protection Act of 2010
Client: DOLLAR BANK · Firm: BUCHANAN INGERSOLL & ROONEY PC
Banking issues related to charter HR 5387 S 3264
Debt Settlement Consumer Protection Act of 2010
Client: DOLLAR BANK · Firm: BUCHANAN INGERSOLL & ROONEY PC
Banking issues related to charter HR 5387 S 3264
Food Safety and Tracking Improvement Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425
Food Safety and Tracking Improvement Act
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425.
Food Safety and Tracking Improvement Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation
Food Safety and Tracking Improvement Act
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425.
Food Safety and Tracking Improvement Act
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425.
Food Safety and Tracking Improvement Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425
Food Safety and Tracking Improvement Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425
Food Safety and Tracking Improvement Act
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425.
American Middle Class Tax (AMT) Relief Act of 2007
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425.
American Middle Class Tax (AMT) Relief Act of 2007
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425.
American Middle Class Tax (AMT) Relief Act of 2007
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425.
American Middle Class Tax (AMT) Relief Act of 2007
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425.
Superfund Polluter Pays Act
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425.
Superfund Polluter Pays Act
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425.
Superfund Polluter Pays Act
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425.
Superfund Polluter Pays Act
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590, HR 3962 and S.425.
American Middle Class Tax (AMT) Relief Act of 2007
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590 and HR 3962
American Middle Class Tax (AMT) Relief Act of 2007
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590 and HR 3962.
Superfund Polluter Pays Act
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590 and HR 3962.
Superfund Polluter Pays Act
Client: MCDONALD'S CORPORATION · Firm: BUCHANAN INGERSOLL & ROONEY PC
Issues related to health care reform specifically HR 3590 and HR 3962
To designate the facility of the United States Postal Service located at 1155 Seminole Trail in Charlottesville, Virginia, as the "Corporal Bradley T. Arms Post Office Building".
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
H.R.5631, S.2766.
To designate the facility of the United States Postal Service located at 1155 Seminole Trail in Charlottesville, Virginia, as the "Corporal Bradley T. Arms Post Office Building".
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
HR. 5631, S. 2766
To designate the facility of the United States Postal Service located at 1155 Seminole Trail in Charlottesville, Virginia, as the "Corporal Bradley T. Arms Post Office Building".
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
HR. 5631, S. 2766
H.R.5631, S.2766.
HR. 5631, S. 2766
HR. 5631, S. 2766
Providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Centers for Medicare & Medicaid Services within the Department of Health and Human Services relating to Medicare coverage for the use of erythropoiesis stimulating agents in cancer and related neoplastic conditions.
Client: US ONCOLOGY · Firm: BUCHANAN INGERSOLL & ROONEY PC
HJ Res 54
Fair Medicaid Drug Payment Act of 2007
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
HR 3700
Fair Medicaid Drug Payment Act of 2007
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
HR 3700
To designate the facility of the United States Postal Service located at 1155 Seminole Trail in Charlottesville, Virginia, as the "Corporal Bradley T. Arms Post Office Building".
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
HR 5631, S. 2766
To designate the facility of the United States Postal Service located at 1155 Seminole Trail in Charlottesville, Virginia, as the "Corporal Bradley T. Arms Post Office Building".
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
H.R.5631, S.2766
To designate the facility of the United States Postal Service located at 1155 Seminole Trail in Charlottesville, Virginia, as the "Corporal Bradley T. Arms Post Office Building".
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
HR 5631, S. 2766
To designate the facility of the United States Postal Service located at 1155 Seminole Trail in Charlottesville, Virginia, as the "Corporal Bradley T. Arms Post Office Building".
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
H.R.5631, S.2766
To designate the facility of the United States Postal Service located at 1155 Seminole Trail in Charlottesville, Virginia, as the "Corporal Bradley T. Arms Post Office Building".
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
H.R.5631, S.2766
H.R.5631, S.2766
H.R.5631, S.2766
HR 5631, S. 2766
H.R.5631, S.2766
HR 5631, S. 2766
Local Control of Cellular Towers Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
H.R.5631, S.2766
Local Control of Cellular Towers Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
H.R.5631, S.2766
Local Control of Cellular Towers Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
H.R.5631, S.2766
Local Control of Cellular Towers Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
H.R.5631, S.2766
Local Control of Cellular Towers Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
H.R.5631, S.2766
Local Control of Cellular Towers Act
Client: WALGREEN CO · Firm: BUCHANAN INGERSOLL & ROONEY PC
H.R.5631, S.2766
Health information technology; organized retail crime bill; drug pedigree legislation; health care reform; S.425 implementation; TRICARE issues; MTM legislation
Health information technology; organized retail crime bill; drug pedigree legislation; health care reform; S.425 implementation; TRICARE issues; MTM legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAINT JOSEPH'S UNIVERSITY via BUCHANAN INGERSOLL & ROONEY PC
2014 · fourth_quarter · Q4
Government Relations counseling focused on issues related to higher Education, transportation, and policies dealing autism awareness
Government Relations counseling focused on issues related to higher Education, transportation, and policies dealing autism awareness
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EQT CORPORATION via BUCHANAN INGERSOLL & ROONEY PC
2014 · fourth_quarter · Q4
Issues related to the regulation of shale gas production and pipeline safety initiatives
Issues related to the regulation of shale gas production and pipeline safety initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF PITTSBURGH MEDICAL CENTER via BUCHANAN INGERSOLL & ROONEY PC
2014 · fourth_quarter · Q4
HR 4302, Protecting Access to Medicare Act of 2014, PL113-93, 101, 107, 109, 212, 218, 221; HR 4015, SGR Repeal & Medicare Provider Payment Modernization Act of 2014; 2 & 4; S 2110, Medicare SGR Repeal & Beneficiary Access Improvement Act of 2014; 101, 103, 206, 404; ICD-10 Implementation; Medicaid & CHIP Payment and Access Commission - call for nominations; Liver Transplant Request and Medicare Administrative Contractor; Draft legislation by Ways and Means to Improve Hospital Issues; Quality Reporting Measures
Implementation of PL111-148; hospital & Insurance issues
Implementation of PL111-148; S. 2450, HR 4810, Veterans Affairs Policy for Organ Transplant; specialty drugs' effect on health care premiums; long-term care policies
HR 83; Consolidated and Further Continuing Appropriations Act, 2015;; hospital and insurance issues
J-1 Visa requests for physicians
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HIGHMARK WHOLECARE (FORMERLY GATEWAY HEALTH PLAN, LP.) via BUCHANAN INGERSOLL & ROONEY PC
2014 · fourth_quarter · Q4
Health care regulatory matters; Medicare & Medicaid advantage; general issues; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; new product offerings for Medicare & Medicaid
Implementation of PL111-148; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; specialty drugs' effects on health care premiums
HR 83; Consolidated and Further Continuing Appropriations Act, 2015; General issues related to budget
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
BROWN'S COMPOUNDING via BUCHANAN INGERSOLL & ROONEY PC
2014 · fourth_quarter · Q4
Tricare reimbursement; basic insurance policies affecting the industry
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies; HR 83; Consolidated and Further Continuing Appropriations Act, 2015
WALGREEN CO via BUCHANAN INGERSOLL & ROONEY PC
2014 · third_quarter · Q3
Health information technology; organized retail crime bill; drug pedigree legislation; health care reform; S.425 implementation; TRICARE issues; MTM legislation
Health information technology; organized retail crime bill; drug pedigree legislation; health care reform; S.425 implementation; TRICARE issues; MTM legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S INSTITUTE via BUCHANAN INGERSOLL & ROONEY PC
2014 · third_quarter · Q3
Appropriations funding; labor HHS Education appropriations; CMMI Grant Congressional support
Appropriations funding; labor HHS Education appropriations; CMMI Grant Congressional support
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SABER HEALTHCARE GROUP via BUCHANAN INGERSOLL & ROONEY PC
2014 · third_quarter · Q3
Regulatory Issues
Regulatory Issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAINT JOSEPH'S UNIVERSITY via BUCHANAN INGERSOLL & ROONEY PC
2014 · third_quarter · Q3
Government Relations counseling focused on issues related to higher Education, transportation, and policies dealing with autism awareness.
Government Relations counseling focused on issues related to higher Education, transportation, and policies dealing with autism awareness.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EQT CORPORATION via BUCHANAN INGERSOLL & ROONEY PC
2014 · third_quarter · Q3
Issues related to the regulation of shale gas production and pipeline safety initiatives
Issues related to the regulation of shale gas production and pipeline safety initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUNICH RE AMERICA via BUCHANAN INGERSOLL & ROONEY PC
2014 · second_quarter · 2T
Implementation of Affordable Care Act
UNIVERSITY OF PITTSBURGH MEDICAL CENTER via BUCHANAN INGERSOLL & ROONEY PC
2014 · third_quarter · Q3
Implementation of PL111-148; S. 2450, HR 4810, Veterans Affairs Policy for Organ Transplant; specialty drugs' effect on health care premiums; long-term care policies.
Proposed FY 2015 Administrative Budget; hospital and insurance issues
HR 4302, Protecting Access to Medicare Act of 2014, PL113-93, 101, 107, 109, 212, 218, 221; HR 4015, SGR Repeal & Medicare Provider Payment Modernization Act of 2014; 2 & 4; 2015 Medicare Advantage (MA) Capitation Rates, Parts C&D Payment Policies & 2015 Call Letter, (4.7.14); S 2110, Medicare SGR Repeal & Beneficiary Access Improvement Act of 2014; 101, 103, 206, 404; ICD-10 Implementation; Medicaid & CHIP Payment and Access Commission - call for nominations
HIGHMARK WHOLECARE (FORMERLY GATEWAY HEALTH PLAN, LP.) via BUCHANAN INGERSOLL & ROONEY PC
2014 · third_quarter · Q3
Proposed FY 2015 Federal Budget by Administration, March 4, 2014; General issues related to budget
Implementation of PL111-148; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; specialty drugs' effects on health care premiums
Health care regulatory matters; Medicare & Medicaid advantage; general issues; 2015 Medicare Advantage (MA) Capitation Rates, Parts C & D Payment Policies & 2015 Call Letter (4.7.14); Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; new product offerings for Medicare & Medicaid
BROWN'S COMPOUNDING via BUCHANAN INGERSOLL & ROONEY PC
2014 · third_quarter · Q3
Tricare reimbursement; basic insurance policies affecting the industry.
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies; Drug Quality and Security Act PL113-54
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
MUNICH RE AMERICA via BUCHANAN INGERSOLL & ROONEY PC
2014 · second_quarter · Q2
Implementation of Affordable Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF PITTSBURGH MEDICAL CENTER via BUCHANAN INGERSOLL & ROONEY PC
2014 · second_quarter · Q2
Proposed FY 2015 Administrative Budget; hospital and insurance issues
Implementation of PL111-148; 2015 Medicare Advantage (MA) Capitation Rates, Parts C&D Payment Policies & 2015 Call Letter, (4.7.14); Proposed FY 2015 Administrative Budget; hospital & Insurance issues.
Implementation of PL111-148; S. 2450, HR 4810, Veterans Affairs Policy for Organ Transplant; specialty drugs' effect on health care premiums; long-term care policies.
WALGREEN CO via BUCHANAN INGERSOLL & ROONEY PC
2014 · second_quarter · Q2
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation, TRICARE issues; MTM legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S INSTITUTE via BUCHANAN INGERSOLL & ROONEY PC
2014 · second_quarter · Q2
Appropriations funding; labor HHS Education Appropriations; CMMI Grant Congressional Support
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SABER HEALTHCARE GROUP via BUCHANAN INGERSOLL & ROONEY PC
2014 · second_quarter · Q2
Regulatory issues
Regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIGHMARK WHOLECARE (FORMERLY GATEWAY HEALTH PLAN, LP.) via BUCHANAN INGERSOLL & ROONEY PC
2014 · second_quarter · Q2
1. Proposed FY 2015 Federal Budget by Administration, March 4, 2014 2. General issues related to budget
Health care regulatory matters; Medicare & Medicaid advantage; general issues; * 2015 Medicare Advantage (MA) Capitation Rates, Parts C & D Payment Policies & 2015 Call Letter (4.7.14); Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107.
Implementation of PL111-148; Protecting Access to Medicare Act of 2014, PL133-93, Sections 101, 107; specialty drugs' effects on health care premiums.
HERITAGE VALLEY HEALTH SYSTEMS via BUCHANAN INGERSOLL & ROONEY PC
2014 · second_quarter · 2T
Healthcare and health programs; appropriations
Regulatory issues related to hospital reimbursement; protecting Access to Medicare Act PL113-93.
Healthcare and health programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROWN'S COMPOUNDING via BUCHANAN INGERSOLL & ROONEY PC
2014 · second_quarter · Q2
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies; Drug Quality and Security Act PL113-54
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
Tricare reimbursement; basic insurance policies affecting the industry.
SAINT JOSEPH'S UNIVERSITY via BUCHANAN INGERSOLL & ROONEY PC
2014 · second_quarter · Q2
Government Relations counseling focused on issues related to higher Education, transportation, and policies dealing autism awareness.
Government Relations counseling focused on issues related to higher Education, transportation, and policies dealing autism awareness.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EQT CORPORATION via BUCHANAN INGERSOLL & ROONEY PC
2014 · second_quarter · Q2
Issues related to the regulation of shale gas production and pipeline safety initiatives
Issues related to the regulation of shale gas production and pipeline safety initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SAINT JOSEPH'S UNIVERSITY via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · Q1
Education, transportation, autism awareness and Veteran's issues.
Education, transportation, autism awareness and Veteran's issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERIC ANIMAL DRUG ALLIANCE via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · Q1
Legislative issues relating to United States Food & Drug Administration.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF PITTSBURGH MEDICAL CENTER via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · Q1
Proposed FY 2015 Administrative Budget; hospital and insurance issues
Proposed FY 2015 Administrative Budget; hospital and insurance issues
General Federal issues, Reimbursement, Implementation of PL111-148
WALGREEN CO via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · Q1
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation, TRICARE issues; MTM legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF THE SCIENCES IN PHILADELPHIA via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · Q1
Higher education issues
Higher education issues.
Higher education issues
Higher education issues.
CHILDREN'S INSTITUTE via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · Q1
Appropriations funding; labor HHS Education Appropriations; CMMI Grant Congressional Support
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SABER HEALTHCARE GROUP via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · Q1
Regulatory issues
Regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUNICH RE AMERICA via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · Q1
Implementation of Affordable Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROWN'S COMPOUNDING via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · Q1
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
HERITAGE VALLEY HEALTH SYSTEMS via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · Q1
Regulatory issues related to hospital reimbursement
Healthcare and health programs.
Healthcare and health programs; appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIGHMARK WHOLECARE (FORMERLY GATEWAY HEALTH PLAN, LP.) via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · Q1
Health care regulatory matters; Medicare & Medicaid advantage; general issues. * S. 2011, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2014, 101, 103, 401; * HR 4015, SGR Repeal and Medicare Provider Payment Modernization Act of 2014, 2, 4; * HR 4302, Protecting Access to Medicare Act of 2014, 101, 107; * Advance Notice of Methodological Changes for Calendar Year (C4) 2015 for Medicare Advantage (MA) Capitation Rates, Parts C & D Payment Policies & 2015 Call Letter
1. Proposed FY 2015 Federal Budget by Administration, March 4, 2014 2. General issues related to budget
EQT CORPORATION via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · Q1
Issues related to the regulation of shale gas production and pipeline safety initiatives
Issues related to the regulation of shale gas production and pipeline safety initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WOCKHARDT LTD via BUCHANAN INGERSOLL & ROONEY PC
2014 · first_quarter · RR
Strategy development and implementation of federal government relations initiatives
Strategy development and implementation of federal government relations initiatives
FERRING PHARMACEUTICALS - USA via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · 4A
Health Care and pharmaceutical issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S INSTITUTE via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Appropriations funding; labor HHS Education Appropriations; CMMI Grant Congressional Support
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS - USA via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Health Care and pharmaceutical issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRECKENRIDGE PHARMACEUTICAL INC via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Health care and pharmaceutical issues within the US House and US Senate.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF PITTSBURGH MEDICAL CENTER via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
General work with CMS on Federal Regulations.
General work with CMS and Congress with regulations pertaining to Medicare, Medicaid & healthcare insurance issues.
General issues relating to Medicare Advantage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WALGREEN CO via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation, TRICARE issues; MTM legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF THE SCIENCES IN PHILADELPHIA via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Hepatitis program funding
Hepatitis program funding
Hepatitis program funding
Hepatitis program funding
SAINT JOSEPH'S UNIVERSITY via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Education, transportation, autism awareness and Veteran's issues.
Education, transportation, autism awareness and Veteran's issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SABER HEALTHCARE GROUP via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Regulatory issues
Regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUNICH RE AMERICA via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Implementation of Affordable Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HERITAGE VALLEY HEALTH SYSTEMS via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Regulatory issues related to hospitals
Healthcare and health programs.
Healthcare and health programs; appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERIC ANIMAL DRUG ALLIANCE via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Legislative issues relating to United States Food & Drug Administration.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HIGHMARK WHOLECARE (FORMERLY GATEWAY HEALTH PLAN, LP.) via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
General work w/HHS on federal regulations.
General federal budget issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
EQT CORPORATION via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Issues related to the regulation of shale gas production and pipeline safety initiatives
Issues related to the regulation of shale gas production and pipeline safety initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROWN'S COMPOUNDING via BUCHANAN INGERSOLL & ROONEY PC
2013 · fourth_quarter · Q4
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
SAINT JOSEPH'S UNIVERSITY via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
Education, transportation, autism awareness and Veteran's issues.
Education, transportation, autism awareness and Veteran's issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
WALGREEN CO via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation, TRICARE issues; MTM legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF PITTSBURGH MEDICAL CENTER via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
General work with CMS and Congress with regulations pertaining to Medicare, Medicaid & healthcare insurance issues.
General work with CMS on Federal Regulations.
General issues relating to Medicare Advantage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNIVERSITY OF THE SCIENCES IN PHILADELPHIA via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
Hepatitis program funding
Hepatitis program funding
Hepatitis program funding
Hepatitis program funding
CHILDREN'S INSTITUTE via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
Appropriations funding; labor HHS Education Appropriations; CMMI Grant Congressional Support
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SABER HEALTHCARE GROUP via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
Regulatory issues
Regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HERITAGE VALLEY HEALTH SYSTEMS via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
Healthcare and health programs.
Healthcare and health programs; appropriations
Regulatory issues related to hospitals
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HIGHMARK WHOLECARE (FORMERLY GATEWAY HEALTH PLAN, LP.) via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
General work w/HHS on federal regulations.
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
General federal budget issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MUNICH RE AMERICA via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
Implementation of Affordable Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERIC ANIMAL DRUG ALLIANCE via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
Legislative issues relating to United States Food & Drug Administration.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS - USA via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
Health Care and pharmaceutical issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EQT CORPORATION via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
Issues related to the regulation of shale gas production and pipeline safety initiatives
Issues related to the regulation of shale gas production and pipeline safety initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRECKENRIDGE PHARMACEUTICAL INC via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
Health care and pharmaceutical issues within the US House and US Senate.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BROWN'S COMPOUNDING via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · Q3
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
BROWN'S COMPOUNDING via BUCHANAN INGERSOLL & ROONEY PC
2013 · third_quarter · RR
Tricare reimbursement; VA clinical studies/ FDA approval; efforts to regulate compounding pharmacies
Tricare reimbursement; VA clinical studies/ FDA approval; efforts to regulate compounding pharmacies
Tricare reimbursement; VA clinical studies/ FDA approval; efforts to regulate compounding pharmacies
MUNICH RE AMERICA via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Implementation of Affordable Care Act
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MUNICH RE AMERICA via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · RR
Implementation of the Affordable Care Act
WALGREEN CO via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation, TRICARE issues; MTM legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF PITTSBURGH MEDICAL CENTER via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
General issues relating to Medicare Advantage.
General work with CMS and Congress with regulations pertaining to Medicare, Medicaid & healthcare insurance issues.
General work with CMS on Federal Regulations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
UNIVERSITY OF THE SCIENCES IN PHILADELPHIA via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Hepatitis program funding
Hepatitis program funding
Hepatitis program funding
Hepatitis program funding
CHILDREN'S INSTITUTE via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Appropriations funding; labor HHS Education Appropriations; CMMI Grant Congressional Support
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEAM WENDY LLC via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Defense Policy and Appropriations.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SAINT JOSEPH'S UNIVERSITY via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Education, transportation, autism awareness and Veteran's issues.
Education, transportation, autism awareness and Veteran's issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SABER HEALTHCARE GROUP via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Regulatory issues
Regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HERITAGE VALLEY HEALTH SYSTEMS via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Healthcare and health programs; appropriations
Healthcare and health programs.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERIC ANIMAL DRUG ALLIANCE via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Legislative issues relating to United States Food & Drug Administration.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HIGHMARK WHOLECARE (FORMERLY GATEWAY HEALTH PLAN, LP.) via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS - USA via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Health Care and pharmaceutical issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EQT CORPORATION via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Issues related to the regulation of shale gas production and pipeline safety initiatives
Issues related to the regulation of shale gas production and pipeline safety initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRECKENRIDGE PHARMACEUTICAL INC via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · Q2
Health care and pharmaceutical issues within the US House and US Senate.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY FOR RADIOLOGY RESEARCH via BUCHANAN INGERSOLL & ROONEY PC
2013 · second_quarter · 2T
Implemention of ACA; disolution of NCRR and creation of NCATS and funding for Imaging Research Health Information Technology. CARE Act; CMMI Congressional grant support
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNIVERSITY OF PITTSBURGH MEDICAL CENTER via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
General work with CMS and Congress with regulations pertaining to Medicare, Medicaid & healthcare insurance issues.
General issues relating to Medicare Advantage.
General work with CMS on Federal Regulations.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
WALGREEN CO via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
Health information technology, organized retail crime bill, drug pedigree legislation, health care reform S.425 implementation, TRICARE issues; MTM legislation
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CHILDREN'S INSTITUTE via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
Appropriations funding; labor HHS Education Appropriations; CMMI Grant Congressional Support
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
TEAM WENDY LLC via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
Defense Policy and Appropriations.
Filing targets: Defense, Dept of (DOD), HOUSE OF REPRESENTATIVES, SENATE
SAINT JOSEPH'S UNIVERSITY via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
Education, transportation, autism awareness and Veteran's issues.
Education, transportation, autism awareness and Veteran's issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
SABER HEALTHCARE GROUP via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
Regulatory issues
Regulatory issues
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HERITAGE VALLEY HEALTH SYSTEMS via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
Healthcare and health programs.
Healthcare and health programs; appropriations
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
GENERIC ANIMAL DRUG ALLIANCE via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
Legislative issues relating to United States Food & Drug Administration.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
HIGHMARK WHOLECARE (FORMERLY GATEWAY HEALTH PLAN, LP.) via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
Health care regulatory matters; Medicare & Medicaid advantage; general issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS - USA via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
Health Care and pharmaceutical issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
EQT CORPORATION via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
Issues related to the regulation of shale gas production and pipeline safety initiatives
Issues related to the regulation of shale gas production and pipeline safety initiatives
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BRECKENRIDGE PHARMACEUTICAL INC via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
Health care and pharmaceutical issues within the US House and US Senate.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACADEMY FOR RADIOLOGY RESEARCH via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · Q1
Implemention of ACA; disolution of NCRR and creation of NCATS and funding for Imaging Research Health Information Technology. CARE Act; CMMI Congressional grant support
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FERRING PHARMACEUTICALS - USA via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · RA
Health care and pharmaceutical issues.
EQT CORPORATION via BUCHANAN INGERSOLL & ROONEY PC
2013 · first_quarter · RR
Issues related to the regulation of shale gas production and pipeline safety initiatives
Issues related to the regulation of shale gas production and pipeline safety initiatives
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies; Drug Quality and Security Act PL113-54
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Implementation of PL111-148; 2015 Medicare Advantage (MA) Capitation Rates, Parts C&D Payment Policies & 2015 Call Letter; Proposed FY 2015 Administrative Budget; hospital & Insurance issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Proposed FY 2015 Administrative Budget; hospital and insurance issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Implementation of PL111-148; Advance Notice of Methodogical Changes for Calendar Year (CY) 2015 for Medicare Advantage (MA) Capitation Rates, Parts C&D Payment Policies & 2015 Call Letter, 2/21/14; Proposed FY 2015 Administrative Budget; hospital & Insurance related issues; Proposed FY 2015 Administrative Budget; hospital and insurance issues
Filing targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Tricare reimbursement; basic insurance policies affecting the industry.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Implementation of PL111-148
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Tricare reimbursement; VA clinical studies/FDA approval; efforts to regulate compounding pharmacies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Tricare reimbursement; VA clinical studies/ FDA approval; efforts to regulate compounding pharmacies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE